# Natural MedTech

> Australian cGMP pharmaceutical manufacturer using biosynthesis (precision fermentation) to make complex controlled-substance active pharmaceutical ingredients (APIs). Commercial products: psilocybin and MDMA. The only psilocybin and MDMA API manufacturer in Australia. This is not an offer to supply to the public; enquiries are professional and via verified channels only.

## Key facts
- Founded 2021, Australia.
- Holds Schedule 8 and Schedule 9 cGMP manufacturing licences; TGO 112 and TGO 113 compliant.
- Supplies both API and finished dose forms; has supplied 10+ Phase 2 (or later) clinical trials in Australia and globally.
- cGMP manufacturing capability across the indole/tryptamine and ergoline molecule families (e.g. psilocin, DMT, 5-MeO-DMT, melatonin, tryptamine, LSD) — capability only, not commercial supply and not an offer to supply.
- Sustainable process: no petrochemicals, no harsh industrial solvents, no plastic waste.

## Pages
- [How it works](https://naturalmedtech.com/how-it-works/): the biosynthesis manufacturing process, step by step.
- [What we make](https://naturalmedtech.com/what-we-make/): commercial APIs, manufacturing capability, and FAQ.
- [About](https://naturalmedtech.com/about/): team, leadership, and credentials.
- [Insights](https://naturalmedtech.com/insights/): articles on biosynthesis, chemistry, and local manufacturing.
- [Contact](https://naturalmedtech.com/contact/): professional enquiry routes (partnerships, prescribers, trial sponsors, investors, media, pharmacovigilance).